NCT's current products are gallium oxide substrates and epi-wafers, which are used for R&D in companies and universities. The company is also funded by competitive grants from public research institutions and joint research with companies. In the future, however, the company expects to generate sales from device products.

In addition to the epi-wafers that we currently sell, NCT is planning to sell gallium oxide diodes by 2022. In addition to the epitaxial wafers that NCT is currently selling, the company is developing and commercializing gallium oxide diodes in order to commercialize them in 2022, and one of its goals is to conduct an initial public offering (IPO) in 2023.